Commentary: From Serendipity to Pilot Study and Then Pivotal Trial: Bimatoprost Topical for Eyelash Growth

被引:5
作者
Cohen, Joel L. [1 ,2 ]
机构
[1] AboutSkin Dermatol & DermSurg, Englewood And Lone Tree, CO USA
[2] Univ Colorado, Dept Dermatol, Denver, CO 80202 USA
关键词
D O I
10.1111/j.1524-4725.2010.01532.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Dr. Cohen has been a consultant and clinical trial investigator for Allergan (including related to Latisse).
引用
收藏
页码:650 / 651
页数:2
相关论文
共 2 条
[1]   Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4 [J].
Williams, R. D. ;
Cohen, J. S. ;
Gross, R. L. ;
Liu, C-c ;
Safyan, E. ;
Batoosingh, A. L. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (10) :1387-1392
[2]   Safety, Effectiveness, and Subjective Experience with Topical Bimatoprost 0.03% for Eyelash Growth [J].
Yoelin, Steve ;
Walt, John G. ;
Earl, Melissa .
DERMATOLOGIC SURGERY, 2010, 36 (05) :638-649